Cargando…
Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands
INTRODUCTION: In the context of the development of pharmaceutical interventions, expectations and experiences of participants are essential. Their insights may be particularly helpful to address the challenges of recruiting and retaining participants for Alzheimer’s disease (AD) clinical trials. We...
Autores principales: | Ottenhoff, Lois, Vijverberg, Everard G. B., Visser, Leonie N. C., Verijp, Merike, Prins, Niels D., Van der Flier, Wiesje M., Sikkes, Sietske A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071606/ https://www.ncbi.nlm.nih.gov/pubmed/37016435 http://dx.doi.org/10.1186/s13195-023-01190-0 |
Ejemplares similares
-
Finding Treatment Effects in Alzheimer Trials in the Face of Disease Progression Heterogeneity
por: Jutten, Roos J., et al.
Publicado: (2021) -
Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report
por: Verrijp, Merike, et al.
Publicado: (2022) -
Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions
por: Waterink, Lisa, et al.
Publicado: (2022) -
Giving meaning to the scores of the Amsterdam instrumental activities of daily living questionnaire: a qualitative study
por: Dubbelman, Mark A., et al.
Publicado: (2022) -
The Cognitive Online Self‐Test Amsterdam (COST‐A): Establishing norm scores in a community‐dwelling population
por: Visser, Leonie N.C., et al.
Publicado: (2021)